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A B S T R A C T
Isolated left ventricular non-compaction (ILVNC) is one of the most misclassified cardiomyopathies. It is caused by
failure of normal embryonic development of the myocardium from loosely arranged muscle fibers to the mature com-
pacted form of myocardium, but it seems that etiology is not exclusively congenital. Diagnosis of ILVNC is mostly missed
because of lack of awareness and knowledge. The recognition of the disease is mandatory, because of its high mortality
and morbidity due to the progressive heart failure, thromboembolic events and lethal arrhythmias. We report of a family
in which two adult members were found to have ILVNC. A literature review about ILVNC pathogenesis, diagnosing, and
treatment was discussed.
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Introduction
Isolated left ventricular non-compaction (ILVNC) is a
congenital cardiomyopathy caused by arrest of normal
embryogenesis of endocardium and myocardium, charac-
terized by multiple prominent myocardial trabeculations
and deep intertrabecular recesses communicating with
the left ventricular cavity1. Although clear diagnostic cri-
teria have been established, ILVNC is not widely known
yet, and as a consequence, its diagnosis is frequently
missed1. Therefore, it could be speculated that frequency
of ILVNC in the general population may have been un-
derestimated. The recognition of the disease is manda-
tory, because of its high mortality and morbidity due to
the progressive heart failure, thromboembolic events
and lethal arrhythmias2–4. The most common findings in
the ILVNC patients are nonspecific abnormalities of the
resting electrocardiography (ECG)1,3. We present a fam-
ily in which ILVNC was revealed in two adult members
by ECG changes.
Case Report
A 26-year-old man was referred to the cardiologist be-
cause of an abnormal ECG, detected in the regular medi-
cal checking. ECG documented a sinus rhythm (80/min),
with ventricular preexcitation evidenced by a short PR
interval, a d wave and repolarization changes (Figure 1).
The patient was asymptomatic, with no history of cardio-
vascular risk factors or previous heart disease. A physical
examination was unremarkable as well as there no ab-
normalities in results of chest radiography and routine
hematological and biochemical parameters. Transthora-
cic echocardiography (TTE) in apical 4-chamber view
showed prominent left ventricular trabeculations with
deep intertrabecular recesses in the lateral wall and apex
of the left ventricle (Figure 2a). Parasternal short axis
view showed a honeycomb-like appearance typical for
ILVNC. The ratio of non-compacted to compacted myo-
cardial layers at the site of maximal wall thickness was
2.7. The color Doppler study showed blood flow from the
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ventricular cavity into the spaces between the prominent
trabeculations throughout the cardiac cycle (Figure 2b).
There was no abnormality in the left ventricular regional
contractility. Cavities size and left ventricular function,
as well as function of the valves were normal. There was
no pericardial effusion. Echocardiographic examination
was interpreted as an ILVNC. Exercise stress imaging
with thallium 201 revealed homogenous uptake of the
radiopharmaceutical throughout the myocardium and
has been described as normal. Holter recordings yielded
no significant arrhythmia. Coronary angiography and
electrophysiological study with eventual radiofrequency
ablation were not considered due to lack of the manifest
clinical indications. Because of echocardiographic pre-
sentation with dense and extensive ILVNC, despite sinus
rhythm and normal left ventricular systolic function, a
chronic anticoagulant therapy with warfarin was initi-
ated with a target INR within the therapeutic range of
2.0–3.0.
Screening over three generations of family members
abnormalities are demonstrated in the patient’s father
only. This 60-year old man has been treated due to di-
lated cardiomyopathy, with highly reduced left ventricu-
lar systolic function (ejection fraction 30%) for 15 years.
His ECG demonstrated atrial fibrillation and left bundle
branch block. Although there were no echocardiographic
abnormalities typical for ILVNC, our opinion is that di-
lated cardiomyopathy in these patient is in the close etio-
pathogenic relationship with ILVNC. He had experienced
an ischemic stroke seven years ago, and after that he re-
ceived permanent anticoagulation. Beside that, there
were no other abnormal neurological findings among
ours cases.
Discussion
ILVNC is a congenital unclassified cardiomyopathy
characterized by multiple prominent myocardial trabe-
culations and deep intertrabecular recesses communicat-
ing with the left ventricular cavity1. ILVNC was initially
described in children, but recent studies have character-
ized this disease in adult populations in whom it may be
missed because of lack of awareness and knowledge4. It
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Fig. 1. Typical electrocardiographic preexcitation pattern with short PR interval, d wave, and repolarization changes. Arrow indicate d
wave.
Fig. 2. a) Apical 4-chamber view, shows dense left ventricular trabeculations with deep intertrabecular recesses. b) Color-flow imaging
shows communication between intertrabecular spaces and the left ventricular cavity. LV – left ventricle, LA – left atria, arrows indicate
non-compacted left ventricle.
seems that etiology is not exclusively congenital: there is
several case reports indicating that noncompaction may
develop or disappear during lifetime5. According to some
speculations in adults the prevalence of ILVNC is 0.014%
to 0.25% per year3,4. However, the real prevalence of
ILVNC among the general population is unknown since
no investigations have been carried out thus far. It is pos-
sible that for that reason, as well as frequently asymp-
tomatic course of the disease, ILVNC in adults is under-
appreciated in prevalence.
ILVNC is most frequently attributed to an arrest of
the physiologic intrauterine compaction process during
embryonic heart development6. During fetal ontogenesis
the developing myocardium gradually condenses and lar-
ge intertrabecular spaces transform into capillaries as
the process of compaction occurs from epicardium to
endocardium and from base toward the apex of the heart,
with trabecular compaction being more complete in the
left ventricular than in the right ventricular myocar-
dium6. The coronary circulation develops concurrently
during this process and the intertrabecular recesses are
reduced to capillaries6. In the abnormal condition, the
compaction process arrests at an early stage, resulted
with deep recesses communicate only with the ventricu-
lar cavity, not the coronary circulation. Abnormal com-
paction process in ILVNC has a segmental distribution
typically affecting apex, lateral and inferior wall of the
left ventricle3,7.
Failure of left ventricular compaction process is possi-
ble caused by mutations in the genes encoding -dystro-
brevin and Cypher/ZASP, integral parts of the complex
which links the extracellular matrix of the myocardial
cell to the cytoskeleton8. This mutation is also common
in the patients with dilated cardiomyopathy and may ex-
plain frequently development of left ventricular dilata-
tion and systolic impairment in patients with ILVNC, as
well as the frequently occurrence of dilative cardiomyo-
pathy and left ventricular enlargement without ILVNC
in relatives of ILVNC patients8. Coronary microcircula-
tory abnormalities play an important role in ILVNC
pathophysiology. Subendocardial perfusion abnormalities
cause ischemia even in the absence of epicardial coronary
disease and may be reason for microscopic necrosis in the
subendocardial area and within trabeculations which
have been documented in histological specimens during
postmortem analysis of ILVNC patients9. Subendocardial
ischemia in ILVNC could be attributed to isometric con-
traction of the endothelium and myocardium within deep
intratrabecular recesses9. The underlying mechanism may
be failure of the coronary microcirculation to grow with
the increase in ventricular mass, or compression of the
intramural coronary vascular bed by the hypertrophied
myocardium, or a combination of both mechanisms9. Ob-
served left ventricular systolic with or without diastolic
dysfunction, arrhythmogenesis and hypokinesis of the
left ventricle may also be consequence of the microcir-
culatory dysfunction9.
Clinical manifestations of ILVNC are highly variable,
ranging from no symptoms to disabling congestive heart
failure, arrhythmias, and systemic thromboembolism1–4.
The most common findings in the IVNC patients are
nonspecific abnormalities of the resting ECG including
left ventricular hypertrophy, inverted T waves, ST seg-
ment changes, axis shifts, intraventricular and atrio-
ventricular conduction abnormalities1–4. Oechslin and al
reported that abnormal ECGs were seen in 94% of ad-
ults, and 56% of them showed ventricular conduction
defect3. Atrioventricular by-pass tract, like in our pa-
tient, has been reported in 13–15% of pediatric ILVNC
patients, but it was not observed in the large observa-
tional studies of adults with ILVNC3. An extensive MED-
LINE search revealed only few relevant reports of pre-
excitation in adult patients with ILVNC10,11. Conduction
abnormalities are possible results of the progressive en-
domyocardial fibrosis in ILVNC and reasonable they are
observed much more frequently in the adult population
because the fibrotic change develops gradually12. Possi-
ble causal link between atrioventricular by-pass tract
and ILVNC is unclear. The WPW syndrome is thought to
arise from a failed regression of developmental embryo-
logic atrioventricular anatomical and electrical continu-
ity attributable to abnormal embryologic persistence of
atrioventricular muscular continuity, which can also be
seen in the failing regression of noncompacted myo-
cardium in ILVNC13. The final separation of the right
atrium from the right ventricle is part of the normal
postnatal development, and it has been hypothesized
that, as like as a normal process of compaction, the nor-
mal process of development of the annulus fibrosus after
birth is also arrested13. ILVNC are also frequently associ-
ated with extra-cardiac manifestations in particular neu-
romuscular diseases, so it seems that is necessary exten-
sive neurological and genetic testing, even in asymptom-
atic cases5.
TTE is the gold standard for ILVNC diagnosis1,7. Four
clear-cut echocardiographic diagnostic criteria have been
established: 1) absence of coexisting cardiac abnormali-
ties; 2) a 2-layered structure of the left ventricular wall,
with the end systolic ratio of noncompacted to compacted
layer >2; 3) finding this structure predominantly in the
apical and mid-ventricular areas; and 4) blood flow di-
rectly from the ventricular cavity into the deep intertra-
becular recesses as assessed by Doppler echocardiogra-
phy1,7. Different echocardiographic diagnostic criteria also
exist and overdiagnosis as well as missing of the diagno-
sis occurs5. Other modalities including transesophageal
echocardiography (TEE), contrast ventriculography, com-
puted tomography (CT) and cardiac magnetic resonance
(CMR) may be also helpful, but no diagnostic criteria for
these modalities have yet been proposed. CT and CMR
guarantees more operator independency and might be
superior to echocardiography in cases of an impaired
echocardiographic imaging quality14. However, it should
be kept in mind that both techniques also claim experi-
enced operators and there are no comparison studies be-
tween these techniques and echocardiography, as well as
the lack of large studies comparing pathoanatomic with
echocardiographic or other imaging studies. Because myo-
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cardial perfusion and coronary flow reserve in areas of
ILVNC are impaired, CMR, PET and thallium-201 scin-
tigraphy may be helpful in detection of subendocardial
perfusion defects in these patients13. Although PET, CMR,
echocardiography and ventriculography are reliable im-
aging modalities to diagnose ILVNC, only PET provides
data to quantify the extent of the myocardial ischemia15.
Treatment of ILVNC patients can be divided into the
two categories regarding to clinical presentation and left
ventricle function. In symptomatic ILVNC patients or in
the patients with asymptomatic left ventricular dysfunc-
tion, treatment should consider for three major clinical
manifestations: heart failure, arrhythmias and embolic
events3,4. Treatment strategies for symptomatic ventric-
ular arrhythmias in ILVNC are comparable to those cur-
rently recommended in cardiomyopathies, with special
attention to proarrhythmic drug effects. In most severe
cases, those with documented sustained ventricular ar-
rhythmias, in NYHA classes III and IV, and/or severely
dilated left ventricles, treatment of choice are implanta-
tion of automated cardioverter defibrillator or heart trans-
plantation3,4. On the other hand, management of the
asymptomatic ILVNC patients with preserved left ven-
tricular function and no standard thromboembolic risk
factors (e.g. atrial fibrillation, prior embolic event, age
>75 year, diabetes) is more difficult. Despite an increas-
ing interest in this disorder until to date there have not
been clinical studies to show potential differences in out-
come in this group of ILVNC patients treated with anti-
coagulants, ACE-inhibitors, beta-blockers or amiodaro-
ne. Therefore, there are no clear recommendations about
necessity of medical treatment for asymptomatic ILVNC
patients with preserved left ventricular function. How-
ever, it has been reported that the majority of ILVNC pa-
tients who were asymptomatic at presentation developed
left ventricular dysfunction within 6 years of diagnosis3.
Although, it has been reported beneficial effect of car-
vedilol in infants with ILVNC on left ventricular func-
tion, mass and both metabolic and adrenergic abnor-
malities16, there are no effectiveness data of early car-
vedilol treatment in adult ILVNC patients with pre-
served left ventricular function. Indeed, there is no uni-
form opinion about necessity of preventive permanent
anticoagulation. Contrary to opinion that even ILVNC
patients with sinus rhythm and normal left ventricular
systolic function should be anticoagulated3,4,17, some au-
thors suggests that thrombus-formation is a rare event
in patients with ILVNC, and that ILVNC by itself does
not seem to be an embolic risk factor18. However, throm-
boembolic events have been observed in young patients
with sinus rhythm and normal left ventricular func-
tion19. Therefore, treatment for asymptomatic ILVNC
patients with preserved left ventricular function should
be individualized. In that context, we stress potential
role of echocardiography in decision making of necessity
for permanent anticoagulation and treatment with ACE-
-inhibitor and carvedilol20. By our opinion, ILVNC pa-
tients with dense and extensive hypertrabeculations, even
in the case of preserved ventricular function and no addi-
tionally embolic risk factors should be anticoagulated.
Contrary, ILVNC patients with similar clinical character-
istics, but with a rare trabeculations and capacious inter-
trabecular spaces, may be treated with low-dose aspirin
(325 mg/day). Also, echocardiographic documented
ILVNC is a reliable reason for initiating therapy with
carvedilol and ACE-inhibitor titrating up to maximal tol-
erable doses20.
Conclusively, we recommend that in patients with
non-specific ECG abnormalities ILVNC should be consid-
ered. Echocardiography is mandatory in the ILVNC pa-
tients’ first-degree relatives due to frequent findings of
ILVNC, dilated cardiomyopathy, and left ventricular en-
largement. Due to high possibility of left ventricular dys-
function development, initiating carvedilol and ACE-in-
hibitor are recommended.
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IZOLIRANA NEKOMPAKTNA KARDIOMIOPATIJA LIJEVE KLIJETKE S PREEKSCITACIJOM –
PRIKAZ SLU^AJA
S A @ E T A K
Izolirana nekompaktna kardiomiopatija lijeve klijetke jedna je od naj~e{}e neprepoznatih kardiomiopatija. Poslje-
dica je zastoja u normalnom embrionalnom razvoju miokarda tijekom kojeg iz neorganiziranih mi{i}nih vlakana nasta-
je zreli kompaktni miokard. Ova kardiomiopatija se ~esto previ|a zbog nedostatnog poznavanja ovog entiteta. Dijagnosti-
ciranje je osobito zna~ajno zbog visokog pobola i smrtnosti, kojima su uzroci progresivno zatajenje srca, tromboembo-
lijski incidenti i maligne aritmije. U radu je prikazana obitelj, u kojoj je dijagnosticirana izolirana nekompaktna kardio-
miopatija lijeve klijetke u dva odrasla ~lana. Tako|er se iznose trenutne spoznaje u svezi s patogenezom, dijagnostikom
i lije~enjem bolesnika s izoliranom nekompaktnom kardiomiopatijom lijeve klijetke.
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